Description

The impact of chronic diseases on people is growing year by year due to factors such as changing lifestyles and an aging society.
Due to demographic changes and advances in medical technology, it is believed that the disease structure will shift from acute diseases such as infectious diseases to chronic diseases.
Efforts to treat chronic diseases both domestically and internationally are shifting toward home medical care, and there is an urgent need to bring to market corresponding administration devices.
Nipro has signed an agreement with global medical device manufacturer Haselmeier GmbH*1 for the exclusive distribution in Japan of PiccoJect™, an autoinjector developed for simple and safe medication administration using prefilled syringes.
We would like to introduce this device to you.

*1 About Haselmeier

Haselmeier is a division of medmix (headquarters: Baar, Switzerland; CEO: Girts Cimermans), a Swiss company that manufactures and sells medical devices worldwide. With 19 locations around the world, Haselmeier has been developing and manufacturing high-quality administration devices for over 100 years.